Novavax Q1 2025: Balance Sheet Shifts
Ticker: NVAX · Form: 10-Q · Filed: May 8, 2025 · CIK: 1000694
| Field | Detail |
|---|---|
| Company | Novavax Inc (NVAX) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, balance-sheet
Related Tickers: NVAX
TL;DR
NVAX Q1 2025: Equity up, Retained Earnings down. Balance sheet is shifting.
AI Summary
Novavax Inc. reported its first quarter 2025 results, ending March 31, 2025. The company's revenue for the quarter was not explicitly stated in this excerpt, but it did report changes in its balance sheet accounts, including increases in Additional Paid-In Capital and Common Stock, and decreases in Retained Earnings and Treasury Stock.
Why It Matters
Changes in these balance sheet accounts can indicate the company's financial health, including its ability to raise capital and manage its equity.
Risk Assessment
Risk Level: medium — The filing provides limited financial performance data, making a full assessment of risk difficult.
Key Numbers
- 2025-03-31 — End of Quarter (Reporting period for the 10-Q)
- 2025-01-01 — Beginning of Quarter (Reporting period for the 10-Q)
Key Players & Entities
- NOVAVAX INC (company) — Filer
- 20250331 (date) — End of reporting period
- 20250508 (date) — Filing date
FAQ
What were Novavax's total revenues for the first quarter of 2025?
The provided excerpt does not explicitly state Novavax's total revenues for the first quarter of 2025.
What is the company's fiscal year end?
Novavax Inc.'s fiscal year ends on December 31.
In which state was Novavax Inc. incorporated?
Novavax Inc. was incorporated in Delaware (DE).
What is the business address of Novavax Inc.?
The business address is 700 Quince Orchard Road, Gaithersburg, MD 20878.
What was the change in Retained Earnings from December 31, 2024, to March 31, 2025?
The excerpt indicates a change in Retained Earnings between these dates, but the specific amount of decrease is not detailed in this snippet.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding NOVAVAX INC (NVAX).